U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610746) titled 'Cerebral Physiology of NOWS' on May 11.
Brief Summary: This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Neonatal Opioid Withdrawal
Neonatal Opioid Withdrawal Syndrome
Opioid Use Disorder
Intrauterine Exposure
Intervention:
DEVICE: FD-NIRS and DCS
The investigators will use a novel optical-based device that combines two advanced NIRS techniques, frequency-domain NIRS (FD-NIRS) and diffuse correlation...